• Prospectus issued for SPP Offer of up to $1.0 million
• SPP Offer to raise funds through issue of up to $30,000 of Shares at $0.05 each
• Offer subject to Shareholder approval at the General Meeting on 24 July 2026
• Prospectus available for Australian and New Zealand investors only

Microba Life Sciences Ltd has issued a prospectus for a Securities Purchase Plan (SPP) to raise up to $1.0 million. The offer involves issuing up to $30,000 of shares at $0.05 each, with one free attaching option for every share issued, exercisable at $0.0625 each on or before the date that is three years following their issue. The SPP Offer is not underwritten. The offer is subject to Shareholder approval at the General Meeting on 24 July 2026. Additionally, the company is offering 100,004,240 new options to Placement Subscribers, exercisable at $0.0625 each on or before the date that is three years following their issue. The issue of new options under the Placement Options Offer is also subject to Shareholder approval at the General Meeting. The SPP Offer is scheduled to close at 5:00pm (AEST) on Wednesday, 22 July 2026. Valid applications must be received by that time. The prospectus is available for Australian and New Zealand investors only.